Location: New York, NY
CIK: 0001615982 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: May 15, 2023
Total Value: $508M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Tricida Inc | 7,132,079 | $69.04M | 13.6% | $9.15 | — | COM | 89610F101 |
| ACRS | Aclaris Therapeutics Inc | 4,563,962 | $63.71M | 12.5% | $13.57 | +3.3% | COM | 00461U105 |
| RLMD | Relmada Therapeutics Inc | 2,270,072 | $43.11M | 8.5% | $31.54 | -30.8% | COM | 75955J402 |
| TVTX | Travere Therapeutics Inc | 1,711,102 | $41.46M | 8.2% | $19.66 | +27.9% | COM | 89422G107 |
| COGT | Cogent Biosciences Inc | 4,038,117 | $36.42M | 7.2% | $7.95 | -14.1% | COM | 19240Q201 |
| GHRS | GH Research PLC | 3,185,573 | $31.79M | 6.3% | $17.93 | -27.5% | ORD SH | G3855L106 |
| — | Instil Bio Inc | 5,997,657 | $27.71M | 5.5% | $25.08 | — | COM | 45783C101 |
| CLDX | Celldex Therapeutics Inc | 865,116 | $23.32M | 4.6% | $15.71 | +84.9% | COM | 15117B202 |
| VRDN | Viridian Therapeutics Inc | 1,852,919 | $21.44M | 4.2% | $18.59 | -27.7% | COM | 92790C104 |
| — | VistaGen Therapeutics Inc | 20,697,286 | $18.21M | 3.6% | $1.76 | — | COM | 92840H202 |
| — | Marinus Pharmaceuticals Inc | 3,156,803 | $15.28M | 3.0% | $11.98 | — | COM | 56854Q200 |
| WHWK | Aadi Bioscience Inc | 1,173,518 | $14.46M | 2.8% | $30.48 | -51.3% | COM | 00032Q104 |
| — | Inozyme Pharma Inc | 2,709,987 | $12.93M | 2.5% | $4.77 | — | COM | 45790W108 |
| — | Akouos Inc | 2,667,119 | $12.51M | 2.5% | $4.69 | — | COM | 00973J101 |
| LIANY | LianBio | 5,378,341 | $11.62M | 2.3% | $6.16 | — | SPONS ADR | 53000N108 |
| — | Aerovate Therapeutics Inc | 590,408 | $9.228M | 1.8% | $16.32 | — | COM | 008064107 |
| TRVI | Trevi Therapeutics Inc | 3,050,022 | $8.571M | 1.7% | $2.46 | 0.0% | COM | 89532M101 |
| — | Chinook Therapeutics Inc | 489,618 | $8.563M | 1.7% | $16.31 | — | COM | 16961L106 |
| ANNX | Annexon Inc | 1,928,477 | $7.27M | 1.4% | $3.06 | 0.0% | COM | 03589W102 |
| SVRA | Savara Inc | 4,117,530 | $6.259M | 1.2% | $1.26 | +4.0% | COM | 805111101 |
| — | Lyra Therapeutics Inc | 924,170 | $5.222M | 1.0% | $5.65 | — | COM | 55234L105 |
| — | Provention Bio Inc | 1,118,653 | $4.475M | 0.9% | $7.32 | — | COM | 74374N102 |
| ALT | Altimmune Inc | 369,306 | $4.321M | 0.9% | $7.36 | -16.3% | COM | 02155H200 |
| ATYR | aTyr Pharma Inc | 1,398,889 | $3.959M | 0.8% | $5.98 | -39.6% | COM | 002120202 |
| — | Affimed NV | 1,428,571 | $3.957M | 0.8% | $5.52 | — | COM | N01045108 |
| — | Rallybio Corp | 268,532 | $2.027M | 0.4% | $7.55 | — | COM | 75120L100 |
| XENE | Xenon Pharmaceuticals Inc | 30,000 | $913K | 0.2% | $30.24 | 0.0% | COM | 98420N105 |